Jasper Therapeutics, Inc. — Director's Dealing 2021

Apr 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amplitude Healthcare Acquisition Corp (AMHC)
CIK: 0001788028
Period of Report: 2021-04-21

Reporting Person: GLAZER CAPITAL, LLC (10% Owner)
Reporting Person: GLAZER PAUL J (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-21	Class A common stock, par value $0.0001 per share	S	1164	$9.92	Disposed	1046778	Indirect
2021-04-23	Class A common stock, par value $0.0001 per share	S	151719	$9.92	Disposed	895059	Indirect

Footnotes

F1: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.